NDAINTRAVENOUSPOWDER
Approved
Jan 2021
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
ACETAMINOPHEN (acetaminophen) by Gland Pharma is 12. Approved for minor aches, pains due to: headache sore throat flu toothache the common cold temporarily reduces fever. First approved in 2021.
Drug data last refreshed 1h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Acetaminophen is a generic analgesic and antipyretic agent available as an intravenous powder formulation for injection. It treats minor aches and pains including headache, sore throat, flu-related symptoms, toothache, and common cold, while temporarily reducing fever. The precise mechanism is not fully established but is thought to involve primarily central nervous system actions.
Peak
Peak lifecycle stage suggests stable market presence with mature team structures, though generic status limits growth potential and may indicate smaller dedicated team size.
Mechanism of Action
12.1 Mechanism of Action The precise mechanism of the analgesic and antipyretic properties of acetaminophen is not established but is thought to primarily involve central actions. 12.2 Pharmacodynamics Acetaminophen has been shown to have analgesic and antipyretic activities in animal and human…
Worked on ACETAMINOPHEN at Gland Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.